Which TSX Cannabis Stocks Should You Buy Today?

Canadians eyeing upside in the legal cannabis space have some strong options. Here’s why names like Canopy Growth Corp (TSX:WEED)(NYSE:CGC) stand out.

edit Cannabis leaves of a plant on a dark background

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Cannabis investing may seem too risky for the current market. But several names in the Canadian pot stock space have been proving solidly resistant lately. Are cannabis stocks immune to the crushing market forces that have made mincemeat of other industries? Let’s review some of the top picks for investors looking to pack some green upside in a stock portfolio.

This is still a stock-picker’s market. The cannabis space is much too uneven for safe indexing. Look at the Horizons Marijuana Life Sciences ETF, down 23% in the last three months. Granted, some names, even perennially popular ones like Village Farms, have fared worse than the industry average. Village Farms is down 35% since February. But Aphria was down 17% in that time, matching the TSX point-for-point.

Cannabis stocks have a clear market leader

Two words make Canopy Growth stand out right now: “cash runway.” Sure, there are other reasons to get hyped, such as the corporate expertise afforded by the guiding hand of Constellation Brands. Speaking of branding, There’s also the high-tier celebrity endorsements from the likes of Toronto entertainer Drake. In short, Canopy is being cannily positioned as a lifestyle brand, and it’s cash rich enough to ride out the frothy market.

Meanwhile, Aphria runs a tight ship, and it’s this talent for efficiency, illustrated by a run of sturdy quarters, that makes this name a buy. Aphria packs a viable business model underscored by strong medical marijuana market share with access to European markets. In short, this is one of the best names in the Canadian cannabis space for long-term investors.

Like Canopy, HEXO leans into the lifestyle-branding strategy of market penetration. HEXO also released a low-budget play to undercut the competition. However, this was introduced pre-pandemic, so this theme is worth revisiting for a moment. The move is an innovative one, but it may take a while to filter through into HEXO’s market performance. This name is down 62% since February.

Canadians eyeing upside in the legal cannabis space still have some compelling options to mull over. Names like Canopy and Charlotte’s Web Holdings stand out for long-term market dominance, albeit for different reasons. While Canopy is a play for corporate know-how and culture savvy branding, Charlotte’s Web is a buy for CBD market growth south of the border.

Village Farms is another strong stock to buy for ready-made profitability, underpinned by consumer staples defensiveness. Investors should come for the cannabis spinoff, Pure Sunfarms, and stay for the world-class greenhouse expertise. Vegetable crops remain a stabilizing revenue stream and offer some rare diversification in the pot stock space.

The bottom line

Canopy has to be in the top three TSX stocks for marijuana exposure. Aphria is another top-three buy for Canadians looking for wealth creation in a sector with a lot of growth potential. Village Farms belongs in the top tier of Canadian cannabis stocks, given that it is both profitable and well established. The latter stock also has a strong online cannabis sales record.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Victoria Hetherington has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Charlottes Web Holdings, Constellation Brands, and Village Farms International, Inc. The Motley Fool recommends HEXO. and HEXO.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »